| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/29/2014 | CN103536898A Thymopentin (TP-5) drug composition |
| 01/29/2014 | CN103536862A Compound traditional Chinese medicine preparation with effects of benefiting qi and activating blood circulation for preventing and treating gastric cancer, and preparation method thereof |
| 01/29/2014 | CN103536748A Traditional Chinese medicament for treating goiter with depression of liver to generate pathogenic fire |
| 01/29/2014 | CN103536739A Preparation method and application of Zuogui pill |
| 01/29/2014 | CN103536737A Traditional Chinese medicament for treating liver-qi stagnation type thyroid adenoma and preparation method thereof |
| 01/29/2014 | CN103536733A Preparation method and application of rhizoma cyperi pill with ten precious materials |
| 01/29/2014 | CN103536725A Preparation method and application of priceless health restoring powder |
| 01/29/2014 | CN103536713A Medicinal patch for treating bladder diseases |
| 01/29/2014 | CN103536691A Preparation method and application of pills containing schisandra chinensis |
| 01/29/2014 | CN103536674A Medicament composition capable of preventing melanin tumor |
| 01/29/2014 | CN103536660A Compound antileukemie capsules for treating hematological malignancies |
| 01/29/2014 | CN103536659A Traditional Chinese medicine for adjusting dysfunction of qi and blood as well as preparation method thereof |
| 01/29/2014 | CN103536654A Preparation method and application of blended pill of ligusticum wallichii and tea |
| 01/29/2014 | CN103536638A Medicament for treating gastrointestinal dysfunction and preparation method thereof |
| 01/29/2014 | CN103536632A Self-microemulsifying brucea javanica oil oral granules and preparation method thereof |
| 01/29/2014 | CN103536631A Method for preparing enteric stone-like omphalia for treating cancers |
| 01/29/2014 | CN103536628A Toad spermine |
| 01/29/2014 | CN103536626A Magnetic pirarubicin nano-drug composite |
| 01/29/2014 | CN103536623A Potassium magnesium aspartate composition freeze-dried powder for injection |
| 01/29/2014 | CN103536607A Anti-tumor effects of oxytetracycline, propafenone and dipyrone |
| 01/29/2014 | CN103536605A Application of anti-human immunodeficiency virus (HIV) drug amprenavir in preparation of antitumor drug |
| 01/29/2014 | CN103536599A Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 01/29/2014 | CN103536598A Application of compound in preparation of drug for treating liver cancer |
| 01/29/2014 | CN103536594A Application of G-protein-coupled receptor antagonist in preparing medicine for treating glutamate receptor high-expression tumor |
| 01/29/2014 | CN103536593A Use of pyrroloquinoline quinone in preparing medicines for preventing and treating tumors |
| 01/29/2014 | CN103536588A Medical use of benzophenone compound |
| 01/29/2014 | CN103536583A Proanthocyanidin sustained release nano-micro spheres, as well as preparation method and application thereof |
| 01/29/2014 | CN103536574A Coenzyme Q10 soft capsule and preparation method thereof |
| 01/29/2014 | CN103536570A Cimetidine composition lyophilized oral-disintegration tablets |
| 01/29/2014 | CN103536567A Thymopentin (TP-5) powder injection |
| 01/29/2014 | CN103536551A Fluorouracil composition freeze-dried powder for injection |
| 01/29/2014 | CN103536549A Erlotinib composition freeze-dried powder for injection |
| 01/29/2014 | CN103536546A Cyclophosphamide composition freeze-dried powder for injection |
| 01/29/2014 | CN103536545A Daunorubicin composition freeze-dried powder for injection |
| 01/29/2014 | CN103536544A Capecitabine composition freeze-dried powder for injection |
| 01/29/2014 | CN103536537A Preparation method of lung targeted therapeutic medicine gefitinib PLGA [poly(lactic-co-glycolic acid) microspheres |
| 01/29/2014 | CN103536533A Method for preparing liposome of water-soluble drug |
| 01/29/2014 | CN102994222B Method for simultaneously extracting multiple effective components from bitter almond |
| 01/29/2014 | CN102949352B Decitabine freeze-dried powder injection and preparation method thereof |
| 01/29/2014 | CN102895665B Preparation method of targeting graphene nano-grade drug carrier |
| 01/29/2014 | CN102895523B Extraction method of Pseudobulbus Cremastrae seu Pleiones extracts |
| 01/29/2014 | CN102816816B Bacillus sphaericus parasporal crystal protein preparation method and application thereof |
| 01/29/2014 | CN102805756B Application of extract of Chimonanthus Salicifolius. S.Y.H. in preparation of gastric cancer treating medicine |
| 01/29/2014 | CN102755600B Traditional Chinese medicine compound for resisting breast cancer metastasis and reoccurrence, preparation method and uses |
| 01/29/2014 | CN102727891B Modified photosensitizer based on 5-aminolaevulic acid and preparation method thereof |
| 01/29/2014 | CN102670986B Use of Chinese medicinal compound with tongue squamous cell carcinoma resisting effect in preparing the medicine for tongue squamous cell carcinoma |
| 01/29/2014 | CN102657847B Application of toad maggot protein in medicine used for treating rectal cancer |
| 01/29/2014 | CN102617707B Preparation method of new homologue 2-methyl-actinomycin D of actinomycin D |
| 01/29/2014 | CN102603559B Phenylacetyl fluorobenzene salicylamide compound and application thereof |
| 01/29/2014 | CN102552173B Carotenoid oil suspension with high bioavailability and preparation method thereof |
| 01/29/2014 | CN102475687B Decitabine freeze-dry powder injection solution |
| 01/29/2014 | CN102397527B Medicinal composition and application thereof |
| 01/29/2014 | CN102389526B Vacuum freeze-drying method of rhizoma polygonatum |
| 01/29/2014 | CN102363622B Compound and preparation method and use thereof |
| 01/29/2014 | CN102348702B Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
| 01/29/2014 | CN102341112B Method and means for producing tissues and tissues obtained |
| 01/29/2014 | CN102327256B Application of dimethyldiguanide in preparation of medicaments for treating lymphoma diseases |
| 01/29/2014 | CN102267993B Polyhydroxy desmethyl tropane compounds and preparation method and use thereof |
| 01/29/2014 | CN102070485B Method for separating and purifying active component aurantiamide acetate from traditional Chinese medicine clematis terniflora |
| 01/29/2014 | CN102020588B Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof |
| 01/29/2014 | CN101835779B Purine derivatives useful as PI3 kinase inhibitors |
| 01/29/2014 | CN101679470B Method for production of sugar oxazoline derivative |
| 01/29/2014 | CN101679355B Benzimidazole cannabinoid agonists |
| 01/29/2014 | CN101400406B Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 01/28/2014 | US8637672 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 01/28/2014 | US8637659 Mono-and disaccharide derivatives |
| 01/28/2014 | US8637569 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| 01/28/2014 | US8637553 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 01/28/2014 | US8637533 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/28/2014 | US8637523 Compounds for the reduction of beta-amyloid production |
| 01/28/2014 | US8637519 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 01/28/2014 | US8637518 Pyridazinone derivatives |
| 01/28/2014 | US8637513 Heterocycle phenyl amide T-type calcium channel antagonists |
| 01/28/2014 | US8637511 Aminopyrimidines useful as kinase inhibitors |
| 01/28/2014 | US8637509 Azaindazoles |
| 01/28/2014 | US8637499 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture |
| 01/28/2014 | US8637493 Methods for treating glioblastoma |
| 01/28/2014 | US8637466 Multi-arm polymeric alkanoate conjugates |
| 01/28/2014 | US8637451 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/28/2014 | US8637305 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 01/28/2014 | US8637246 BRAF mutations conferring resistance to BRAF inhibitors |
| 01/28/2014 | US8637074 Methods for co-encapsulation of combination drugs and co-encapsulated combination drug product |
| 01/28/2014 | US8637043 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 01/28/2014 | CA2686468C Polyhydroxylated aromatic compounds for the treatment of amyloidosis |
| 01/28/2014 | CA2647592C Inhibitors of polo-like kinases |
| 01/28/2014 | CA2608929C Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 01/28/2014 | CA2599734C Humanized l243 antibodies |
| 01/28/2014 | CA2580749C Quinolone analogs |
| 01/28/2014 | CA2510315C Antibodies against gpr64 and uses thereof |
| 01/28/2014 | CA2481799C Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 01/28/2014 | CA2431916C New therapeutic uses of smr1 peptides |
| 01/23/2014 | WO2014015291A1 FUSED PYRIMIDINES AS INHIBITORS OF p97 COMPLEX |
| 01/23/2014 | WO2014015280A1 Combination therapy of inhibitors for igf1 r and pi3k |
| 01/23/2014 | WO2014015242A1 Measles viruses with reduced susceptibility to neutralization |
| 01/23/2014 | WO2014015235A2 3,5,n-trihydroxy-alkanamide and derivatives: method for making same and use thereof |
| 01/23/2014 | WO2014015175A1 Compositions and methods for modulating brd4 bioactivity |
| 01/23/2014 | WO2014015054A1 Beta amino acid derivatives as integrin antagonists |
| 01/23/2014 | WO2014014901A1 Octahydro-cyclopentapyrrolyl antagonists of ccr2 |
| 01/23/2014 | WO2014014897A2 Immunoglobulin-binding human mycoplasma antigens and methods of use thereof |
| 01/23/2014 | WO2014014314A1 Hetrocyclic derivative having dual inhibitory activity |